CHICAGO (CN) - Thirty-six states will split $181 million from Janssen Pharmaceuticals and Johnson & Johnson, which were accused of pushing the schizophrenia drug Risperdal for off-label uses.
Doctors are allowed to prescribe drugs for off-label uses, but drug companies cannot push the drugs for that.
Janssen's corporate parent Johnson & Johnson did not admit it did anything wrong.
States settled for varying amounts. According to the lawsuits in the Courthouse News database, Illinois sought $50,000 for each consumer law and/or deceptive trade violation; Oregon sought $25,000 per violation, Texas $20,000 per violation, Delaware and Hawaii $10,000 per violation, Alabama $2,000 per violation.
Read more here:
http://www.courthousenews.com/2012/08/31/49842.htm
